Michael Vaughan
Solicitor Advocate, Legal DirectorMichael is a commercial litigator and solicitor advocate who helps companies, public bodies and insurers resolve complex disputes and protect their commercial interests.
He provides clear, practical advice focused on achieving the best outcome, whether through negotiation, court proceedings or alternative dispute resolution.
Michael advises on a wide range of contentious matters, including commercial contract disputes, enforcement of restrictive covenants, director and shareholder disputes, and judicial review. He works closely with clients across a variety of sectors, with particular experience in healthcare and life sciences, helping them understand their options, manage risk and make informed decisions at every stage of a dispute.
He has extensive experience handling litigation in both the Court of Session and Sheriff Courts and regularly appears in court on behalf of clients. His experience has included matters which have lead to applications to the UK Supreme Court and the European Court of Human Rights.
Michael was admitted as a solicitor advocate in 2023, granting him rights of audience in the country's highest civil courts. He is a member of the Law Society of Scotland and the Society of Solicitor Advocates.
Glasgow Tech Week 2026: Wearables and real-time monitoring – who owns the risk?
Using wearable health technology as a practical case study, MFMac's Glasgow Tech Week event on Innovation, Regulation and Real Time Health Monitoring will examine how data protection, cyber security and product liability risks shape innovation across the product lifecycle.
Expanding Your High Street Pharmacy Presence in Scotland
Expanding or relocating a pharmacy in Scotland requires meeting strict regulatory tests, submitting robust evidence, and navigating PPC and potential appeal stages. MFMac guides owners through every step to strengthen applications and protect their position.
Appeal Court rejects "absurd" and "ill founded" interpretations of patent licence agreement
Court upholds royalty payments post-patent expiry in Rocep-Lusol Holdings v Lindal Dispenser, reinforcing the interpretation approach of looking at the contract as a whole, and may combine textual and contextual approaches.